SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnglo-Eastern Plantations Regulatory News (AEP)

Share Price Information for Anglo-Eastern Plantations (AEP)

Share Price is delayed by 15 minutes
Get Live Data
1,644.00    34.00 (2.11%)
Bid:
1,640.00
Ask:
1,658.00
Spread: 18.00 (1.098%)
Market Cap: £630.66m
AEP Live PriceLast checked at - London Stock Exchange

Intraday Anglo-Eastern Plantations Share Chart

Trading Statement

22 May 2018 07:49

RNS Number : 8381O
Anglo-Eastern Plantations PLC
22 May 2018
 

22 May 2018

Anglo-Eastern Plantations Plc

("AEP" or the "Group")

 

Trading Statement

 

The group comprising Anglo-Eastern Plantations Plc ("AEP") and its subsidiaries ("The Group"), is a major producer of palm oil and some rubber across Indonesia and Malaysia, amounting to some 128,200 hectares of which approximately 68,300 hectares (including Plasma) are planted, today announces a trading update in respect of the period since 31 December 2017.

 

 

Operational and financial performance

 

For the first three months ended 31 March 2018, our own production of fresh fruit bunches ("FFB") was 232,400mt, an increase of 4% compared to the same period in 2017 (3M17: 223,900mt).Higher harvest in Riau and Kalimantan compensated for the lower production in North Sumatera plantations due to replanting exercises. FFB bought-in was 211,900mt, which represents a decrease of 12% as competition among new mills intensified in comparison with the same period in 2017 (3M17: 239,800mt). As a result the Crude Palm Oil ("CPO") produced was 91,400mt, 3% lower than the corresponding period in 2017 (3M17: 94,200mt).

 

CPO price ex-Rotterdam averaged $672/mt for the first three months to 31 March 2018. This represents a decline of 13% from the average price of $774/mt recorded in the first quarter of 2017 and is below $678/mt at the start of 2018.

 

The Group's balance sheet remains strong with the Company continuing to generate positive cash flow. The Company's Long Term Development Loans totalled $25.9m as at 31 March 2018 (31 March 2017: $32.7m). The Group has net cash of $117.7m as at 31 March 2018.

 

 

Development

 

The Group's new planting for the three months ended 31 March 2018 totalled 240 hectares (including Plasma). Replanting of about 418 hectares of oil palm in North Sumatera will continue in the second quarter of 2018 and should be completed by the year end.

 

The biogas plant in Kalimantan is expected to commence commercial operation by third quarter of 2018 after installation of about 7 km of medium voltage transmission line.

 

Earthwork on the seventh mill in North Sumatera costing approximately U$19 million has started and should be completed by year end.

 

Outlook

 

The CPO price ex-Rotterdam started the year at $678/mt and reached a peak of $700/mt in the fourth week of February 2018. Since then it has trended downward and closed at $670/mt on 31 March 2018. The CPO price is forecasted to remain weak for the rest of the year due to concerns of oversupply of FFB production in Indonesia and Malaysia and pressure from larger production of competing oil.

 

 

 

 

 

 

 

For further enquiry, contact:

 

Anglo-Eastern Plantations Plc

Dato' John Lim Ewe Chuan

 +44 (0)20 7216 4621

Panmure Gordon (UK) Limited

Andrew Godber

 

+44 (0)20 7886 2500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGLGDUISDBGID
Date   Source Headline
8th Mar 20188:00 amRNSBlock listing Interim Review
8th Nov 20178:00 amRNSTrading Statement
8th Sep 20175:00 pmRNSBlock listing Interim Review
23rd Aug 20175:00 pmRNSInterim Results
27th Jun 20175:01 pmRNSDividend Declaration
27th Jun 20175:00 pmRNSResult of AGM
27th Jun 20177:00 amRNSAGM Statement
26th May 20177:00 amRNSAnnual Financial Report
23rd May 201710:00 amRNSTrading Statement
26th Apr 20176:15 pmRNSDividend Declaration
26th Apr 20174:17 pmRNSDividend Declaration
26th Apr 201712:01 pmRNSPreliminary Results
9th Mar 201710:48 amRNSBlock listing Interim Review
15th Nov 20169:00 amRNSTrading Statement
6th Sep 20169:10 amRNSBlock listing Interim Review
25th Aug 20165:00 pmRNSInterim Results
28th Jun 201610:53 amRNSDividend Declaration
27th Jun 20165:48 pmRNSResult of AGM
27th Jun 20167:00 amRNSAGM Statement
27th May 201610:00 amRNSNotice of AGM and Annual Report
19th May 20167:01 amRNSInterim Management Statement
11th May 20164:40 pmRNSSecond Price Monitoring Extn
11th May 20164:35 pmRNSPrice Monitoring Extension
29th Apr 20165:12 pmRNSDividend Declaration
26th Apr 20164:00 pmRNSFinal Results
6th Apr 20164:40 pmRNSSecond Price Monitoring Extn
6th Apr 20164:35 pmRNSPrice Monitoring Extension
14th Mar 20165:28 pmRNSBlocklisting Interim Review
23rd Feb 20168:44 amRNSTrading Update
29th Jan 20164:40 pmRNSSecond Price Monitoring Extn
29th Jan 20164:35 pmRNSPrice Monitoring Extension
18th Dec 20157:00 amRNSAdoption of FRS 101 - Reduced Disclosure Framework
18th Nov 201510:38 amRNSInterim Management Statement
5th Oct 20158:30 amRNSChange of Adviser
16th Sep 201510:08 amRNSBlocklisting Interim Review
27th Aug 20151:00 pmRNSHalf Yearly Report
18th Aug 201511:57 amRNSTrading Update
30th Jun 20158:30 amRNSResult of AGM
30th Jun 20158:30 amRNSDividend Declaration
29th Jun 20158:30 amRNSAGM Statement
29th May 20159:31 amRNSNotice of AGM
26th May 20159:48 amRNSInterim Management Statement
8th May 201510:30 amRNSDirectorate Change
30th Apr 20157:00 amRNSFinal Results
5th Mar 201510:10 amRNSBlocklisting Interim Review
25th Feb 20154:35 pmRNSPrice Monitoring Extension
18th Nov 20148:00 amRNSInterim Management Statement
27th Aug 20141:18 pmRNSHalf Yearly Report
7th Jul 201410:34 amRNSBlocklisting Interim Review
2nd Jun 20143:46 pmRNSCalculation of dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.